Basics Cassava Sciences, Inc. IPO Date: July 14, 2000 Sector: Healthcare Industry: Pharma Market Cap: $102.9M Activated in VL: True Average Daily Range Avg Daily Range: $1.15 | 4.36% Avg Daily Range (30 D): $0.05 | 2.76% Avg Daily Range (90 D): $0.07 | 3.39% Institutional Daily Volume Avg Daily Volume: 2.63M Avg Daily Volume (30 D): 1.02M Avg Daily Volume (90 D): 1.38M Trade Size Avg Trade Size (Sh.): 126 Avg Trade Size (Sh.) (30 D): 194 Avg Trade Size (Sh.) (90 D): 209 Institutional Trades Total Inst.Trades: 2,706 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $1.5M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.7M Avg Closing Trade (30 D): $.68M Avg Closing Trade (90 D): $1.5M Avg Closing Volume: 70.43K         News Mar 3, 2025 @ 6:00 PM LEQEMBI Market Sales Reflect Growing Confidence in... Source: Delveinsight Feb 8, 2025 @ 4:19 PM SAVA Deadline in 2 Days: Kessler Topaz Meltzer & C... Source: N/A Feb 6, 2025 @ 6:49 PM The Gross Law Firm Announces the Filing of a Secur... Source: The Gross Law Firm Feb 6, 2025 @ 3:03 AM CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER RE... Source: Claimsfiler Feb 5, 2025 @ 9:00 PM SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman, Llc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.48 $-.58 $.13 Diluted EPS $-.48 $-.58 $.13 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -23.4M $ -27.94M $ 6.16M Operating Income / Loss $ -24.59M $ -30.62M $ -61.4M Cost of Revenue $ $ $ Net Cash Flow $ M $ -18.31M $ 86.16M PE Ratio     Splits Dec 21, 2023:   14:10 May 10, 2017:   1:7